Jacobs & Co. CA boosted its stake in Amgen Inc. ( NASDAQ:AMGN – Get Rating ) by 0.2% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,161 shares of the medical research company's stock after acquiring an additional 89 shares during the period. Amgen comprises approximately 1.4% of Jacobs & Co. CA's portfolio, making the stock its 25th largest position. Jacobs & Co. CA's holdings in Amgen were worth $11,159,000 at the end of the most recent reporting period.

https://www.dailypolitical.com/2023/06/26/amgen-inc-nasdaqamgn-shares-purchased-by-jacobs-co-ca.html

#dailypolitical